$2.420
-0.271 (-11.19%)收盘时
DRIO 资讯
DRIO 事件
DarioHealth Expands Contract with Regional Retailer to Include Women's Health Solution
DarioHealth announced that a regional grocery retailer client has expanded its contract with Dario to add Dario Women, the company's recently launched women's health solution supporting women navigating perimenopause and menopause symptoms. The expanded program will be offered to eligible insured employees in January 2027. The client, a regional grocery retailer with over 200 stores and more than 19,000 employees, has used Dario's cardiometabolic solution since the beginning of 2025. Based on employee demand, the client was actively seeking a Women's Health solution in the market and selected Dario's newly-launched program after evaluation in collaboration with their benefit consultant. Dario Women launched in August 2026 as an extension of Dario's provider-backed cardiometabolic platform. The program combines AI-powered engagement, personalized human-led behavioral coaching and access to licensed healthcare providers to support women navigating perimenopause and menopause.
DarioHealth Signs New Contract with Major Health Plan in New Jersey
DarioHealth announced a new contract with a leading health plan in New Jersey, one of the largest in the state representing approximately 1.5M covered lives. The agreement was secured through Dario's strategic channel partnership with Amwell and is expected to launch and begin generating revenue in the first quarter of 2027. The new agreement represents a significant expansion of Dario's reach into large health plan populations and further demonstrates the scalability of the company's channel distribution strategy. As an administrative services only health plan, the customer provides Dario with the opportunity to access a large population of self-funded employer groups that will be able to deploy Dario's cardiometabolic solutions.
DarioHealth Trading Resumes
DarioHealth trading resumes
DarioHealth Trading Halted Due to Volatility
DarioHealth trading halted, volatility trading pause
DarioHealth Launches Integrated GLP-1 Program
DarioHealth announced the launch of Dario's Integrated GLP-1 Program, the first commercial offering built on the company's recently announced collaboration with Beluga Health. Dario has supported members on GLP-1 therapy for years through AI-powered engagement, connected monitoring, nutrition and behavioral coaching. Now, with Beluga's network of licensed healthcare providers, Dario delivers medical evaluation, prescribing of FDA-approved GLP-1 medications where clinically appropriate, and ongoing clinical oversight inside the same platform members already use. Digital care and clinical care are no longer separate. They are one continuous experience under one roof.
相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。







